These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2144465)

  • 41. Transient leukemoid reaction and trisomy 21 mosaicism in a phenotypically normal newborn.
    Brodeur GM; Dahl GV; Williams DL; Tipton RE; Kalwinsky DK
    Blood; 1980 Apr; 55(4):691-3. PubMed ID: 6444534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Transient myeloproliferative disorder in a neonate without Down syndrome].
    Adam M; Vincenot A; Gouraud F; Harvel C; Perot C; Portnoi MF; Andre-Kerneis E; Giraudier S; Leverger G; Favier R
    Ann Biol Clin (Paris); 2007; 65(5):569-73. PubMed ID: 17913678
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transient myeloproliferative syndrome in a phenotypically normal infant.
    Hanna MD; Melvin SL; Dow LW; Williams D; Dahl G; Mirro J
    Am J Pediatr Hematol Oncol; 1985; 7(1):79-81. PubMed ID: 4037246
    [No Abstract]   [Full Text] [Related]  

  • 44. Possible mapping of the gene for transient myeloproliferative syndrome at 21q11.2.
    Niikawa N; Deng HX; Abe K; Harada N; Okada T; Tsuchiya H; Akaboshi I; Matsuda I; Fukushima Y; Kaneko Y
    Hum Genet; 1991 Sep; 87(5):561-6. PubMed ID: 1680787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy for transient myeloproliferative disorder in a premature infant with Down syndrome.
    Oztekin O; Kalay S; Tezel G; Tayfun F; Kupesiz A; Hangul M; Akcakus M; Oygur N
    J Clin Pharm Ther; 2013 Jun; 38(3):262-4. PubMed ID: 23510328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease.
    Bertrums EJ; Buijs A; van Grotel M; Dors N; de Rooij JD; de Haas V; Hopman S; Jongmans MC; Zwaan CM; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27667142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vesiculopustular eruption associated with transient myeloproliferative disorder.
    Nornhold E; Li A; Rothman IL; Lakshminrusimha S; Helm TN
    Cutis; 2009 May; 83(5):234-6. PubMed ID: 19537279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet peroxidase-positive blast cells in transient myeloproliferative disorder with Down's syndrome.
    Suda J; Eguchi M; Ozawa T; Furukawa T; Hayashi Y; Kojima S; Maeda H; Tadokoro K; Sato Y; Miura Y
    Br J Haematol; 1988 Feb; 68(2):181-7. PubMed ID: 2964860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clonal analysis of transient myeloproliferative disorder in Down's syndrome.
    Miyashita T; Asada M; Fujimoto J; Inaba T; Takihara Y; Sugita K; Bessho F; Furukawa T; Mizutani S
    Leukemia; 1991 Jan; 5(1):56-9. PubMed ID: 1825681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transient leukemia with trisomy 21: description of a case and review of the literature.
    Bhatt S; Schreck R; Graham JM; Korenberg JR; Hurvitz CG; Fischel-Ghodsian N
    Am J Med Genet; 1995 Sep; 58(4):310-4. PubMed ID: 8533839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abnormalities of chromosome 1 in myeloproliferative disorders.
    Rowley JD
    Cancer; 1975 Nov; 36(5):1748-57. PubMed ID: 1192363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.
    Carpenter E; Valverde-Garduno V; Sternberg A; Mitchell C; Roberts I; Vyas P; Vora A
    Br J Haematol; 2005 Feb; 128(4):548-51. PubMed ID: 15686466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transient myeloproliferative disorder and acute nonlymphoblastic leukemia in Down syndrome.
    Wong KY; Jones MM; Srivastava AK; Gruppo RA
    J Pediatr; 1988 Jan; 112(1):18-22. PubMed ID: 2961859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transient myeloproliferative disorder associated with trisomy 21: is a short course of chemotherapy indicated in patients with liver impairment and severe clinical problems?
    Rizzari C; Malberti R; Dell'Orto M; Milani M; Jankovic M; Ferrari E; Conter V
    Med Pediatr Oncol; 1999 Jun; 32(6):453-4. PubMed ID: 10358708
    [No Abstract]   [Full Text] [Related]  

  • 55. Risk factors for early death in transient myeloproliferative disorder without phenotypic features of Down syndrome: a case report and literature review.
    Kawase K; Azuma E; Ohshita H; Tanaka T; Hanada Y; Sasaki T; Sugimoto M; Togawa T; Kouwaki M; Ito T; Hirayama M; Koyama N
    J Pediatr Hematol Oncol; 2012 Aug; 34(6):475-9. PubMed ID: 22510770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissociation of a t(12;21) resulting in a normal cell line in two trisomic 21 sons of a nonmosaic t(12;21) father?
    Juberg RC; Stallard R; Mowrey P; Valido CL
    Hum Genet; 1983; 64(3):216-21. PubMed ID: 6224735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Partial trisomy of chromosome 21 by maternal translocation t(15;21) (q26.2; q21)].
    Raoul O; Carpentier S; Dutrillaux B; Mallet R; Lejeune J
    Ann Genet; 1976 Sep; 19(3):187-90. PubMed ID: 136225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Transient myeloproliferative syndrome or congenital leukemia in a newborn infant with Down syndrome?].
    Maszkiewicz W; Zarczynska B; Koralewska J
    Wiad Lek; 1989 May; 42(10):685-8. PubMed ID: 2534337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Transient myeloproliferative disorder (TMD) with transiently increased tetrasomy-21 cells in a phenotypically normal newborn].
    Takeda T; Murano K; Chihara H; Taki M; Watanabe A; Yamada K; Sugita K; Nakazawa S
    Rinsho Ketsueki; 1989 Jul; 30(7):1010-5. PubMed ID: 2810785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transient myeloproliferative disorder in neonates without Down syndrome: case report and review.
    Schifferli A; Hitzler J; Bartholdi D; Heinimann K; Hoeller S; Diesch T; Kühne T
    Eur J Haematol; 2015 May; 94(5):456-62. PubMed ID: 24853125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.